Improving Physical Ability and Cellular Senescence Elimination in HIV

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

November 29, 2026

Study Completion Date

November 29, 2026

Conditions
HIVFrailtyPrefrailAging Problems
Interventions
DRUG

Dasatinib

Dasatinib will be administered as one 100 mg capsule.

DRUG

Quercetin

Quercetin will be administered as five 250 mg capsules.

OTHER

Placebo - Dasatinib

Matching Placebo for Dasatinib will be administered as one 100 mg capsule.

OTHER

Placebo - Quercetin

Matching Placebo for Quercetin will be administered as five 250 mg capsules.

Trial Locations (27)

10010

Weill Cornell Chelsea CRS (Site ID: 7804), New York

10032

Columbia Physicians & Surgeons (P&S) CRS (Site ID: 30329), New York

10065

Weill Cornell Uptown CRS (Site ID: 7803), New York

14642

University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site ID: 31787), Rochester

15213

University of Pittsburgh CRS (Site ID: 1001), Pittsburgh

19104

Penn Therapeutics CRS (Site ID: 6201), Philadelphia

20009

Whitman-Walker Institute, Inc. CRS (Site ID: 31791), Washington D.C.

27401

Greensboro CRS (Site ID: 3203), Greensboro

27599

Chapel Hill CRS (Site ID: 3201), Chapel Hill

35222

Alabama CRS (Site ID: 31788), Birmingham

37204

Vanderbilt Therapeutics (VT) CRS (Site ID: 3652), Nashville

43210

Ohio State University CRS (Site ID: 2301), Columbus

44106

Case CRS (Site ID: 2501), Cleveland

60611

Northwestern University CRS (Site ID: 2701), Chicago

77030

Houston Advancing Research Team CRS (Site ID: 31473), Houston

80045

University of Colorado Hospital CRS (Site ID: 6101), Aurora

90502

Harbor University of California Los Angeles Center CRS (Site ID: 603), Torrance

92103

UCSD Antiviral Research Center CRS (Site ID: 701), San Diego

94143

University of California, San Francisco HIV/AIDS CRS (Site ID: 801), San Francisco

90035-4709

University of California, Los Angeles CARE Center CRS (Site ID: 601), Los Angeles

30308-2012

The Ponce de Leon Center CRS (Site ID: 5802), Atlanta

02114

Massachusetts General Hospital CRS (MGH CRS) (Site ID: 101), Boston

02115

Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS (Site ID: 107), Boston

63110-1010

Washington University Therapeutics (WT) CRS (Site ID: 2101), St Louis

07103

New Jersey Medical School Clinical Research Center CRS (Site ID: 31786), Newark

45267-0405

Cincinnati CRS (Site ID: 2401), Cincinnati

98104-9929

University of Washington Positive Research CRS (Site ID: 1401), Seattle

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT07144293 - Improving Physical Ability and Cellular Senescence Elimination in HIV | Biotech Hunter | Biotech Hunter